BrainStorm Granted Additional US Patent for Its Autologous Stem Cell Technology

 BrainStorm Cell Therapeutics (otcqb:BCLI), a  developer of adult stem cell technologies for neurodegenerative diseases, today announced that the U.S. Patent and Trademark Office has granted the More...